rs1057517990
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_003919.3(SGCE):c.232+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_003919.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SGCE | NM_003919.3 | c.232+1G>T | splice_donor_variant, intron_variant | Intron 2 of 10 | ENST00000648936.2 | NP_003910.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Myoclonic dystonia 11 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 372800). Disruption of this splice site has been observed in individuals with clinical features of SGCE-related conditions (PMID: 16227522, 18175340; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 2 of the SGCE gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SGCE are known to be pathogenic (PMID: 12821748, 15389977, 17853490, 24297365). -
not provided Pathogenic:1
The c.232+1G>T variant in the SGCE gene has been reported previously in a male child with a diagnosis of myoclonus-dystonia syndrome, who had onset of myoclonus in his arms before age 2; the variant was paternally inherited (Raymond et al., 2008). This splice site variant destroys the canonical splice donor site in intron 2. Although this splice site variant is predicted to cause in-frame skipping of exon 2, other variants affecting the canonical splice donor site in intron 2 (c.323+1G>A and c.232+2T>C) have also been reported in the Human Gene Mutation Database in association with myoclonus-dystonia (Stenson et al., 2014), supporting the functional importance of this splice donor site. The c.232+1G>T variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The c.232+1G>T variant is a strong candidate for a pathogenic variant, however, the possibility it may be a rare benign variant cannot be excluded. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at